mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |